Clinical trial
Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia
NCT02298218 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia
- Lead sponsor
- Yonsei University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- December 31, 2011
- Enrollment
- 50 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
biliary atresia, kasai portoenterostomy status